OLIVIA CALLAHAN: Open Payments
NPI 1134602352 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 59 payments from 17 companies in 2025. Trend: 2023 $830 · 2024 $850 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $248 |
| Novo Nordisk Inc | 13 | $222 |
| Lilly USA, LLC | 6 | $102 |
| Astellas Pharma US Inc | 3 | $74 |
| ABBVIE INC. | 4 | $71 |
| Eisai Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
Products named: AIRSUPRA, MOUNJARO, Ozempic, FARXIGA, Rybelsus, Veozah, LINZESS, Leqembi.
Industry payments across TN — which companies pay providers there.
